Companies / Santa Cruz Biotechnology / GAPDH (H-12) HRP
Santa Cruz Biotechnology

GAPDH (H-12) HRP | Santa Cruz Biotechnology

mouse monoclonal IgG2a; GAPDH Antibody (H-12) is an IgG2a κ mouse monoclonal GAPDH antibody that detects GAPDH of mouse, rat and human origin by WB, IP, IF, IHC(P) and ELISA. GAPDH Antibody (H-12) is available as the non-conjugated anti-GAPDH antibody form, as well as multiple conjugated forms of anti-GAPDH antibody, including agarose, HRP, PE, FITC and multiple Alexa Fluor® conjugates. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), also called uracil DNA glycosylase, catalyzes the reversible oxidative phosphorylation of glyceraldehyde-3-phosphate in the presence of inorganic phosphate and nicotinamide adenine dinucleotide (NAD), an important energy-yielding step in carbohydrate metabolism. While GAPDH has long been recognized as playing an integral role in glycolysis, additional functions of GAPDH include acting as a uricil DNA glycosylase, activating transcription, binding RNA and involvement in nuclear RNA export, DNA replication and DNA repair. Expression of GAPDH is upregulated in liver, lung and prostate cancers. GAPDH translocates to the nucleus during apoptosis. GAPDH complexes with neuronal proteins implicated in human neuro-degenerative disorders including the β-Amyloid precursor, Huntingtin and other triplet repeat neuronal disorder proteins.

Reviews


No reviews yet